Bibliography
Le Garrec, D., Gori, S., Luo, L., Lessard, D., Smith, D. C., Yessine, M.-A., Ranger, M., & Leroux, J.-C. (2004). Poly(N-vinylpyrrolidone)-block-poly(d,l-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluation. Journal of Controlled Release, 99(1), 83â101.
References
66
Referenced
203
10.1023/A:1010618632738
/ Invest. New Drugs / Role of formulation vehicles in taxane pharmacology by Van Zuylen (2001){'key': '10.1016/j.jconrel.2004.06.018_bib2', 'first-page': '1454', 'article-title': 'Cremophor EL-mediated alteration of paclitaxel distribution in human blood: clinical pharmacokinetic implications', 'volume': '59', 'author': 'Sparreboom', 'year': '1999', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Cremophor EL-mediated alteration of paclitaxel distribution in human blood: clinical pharmacokinetic implications by Sparreboom (1999)10.1211/0022357021779104
/ J. Pharm. Pharmacol. / Use of a cholesterol-rich emulsion that binds to low-density lipoprotein receptors as a vehicle for paclitaxel by Rodrigues (2002){'key': '10.1016/j.jconrel.2004.06.018_bib4', 'first-page': '1862', 'article-title': 'Phase I trial in advanced malignancies with liposome-encapsulated paclitaxel (LEP) Q 3 weeks', 'volume': '21', 'author': 'Bowden', 'year': '2002', 'journal-title': 'Proc. Am. Soc. Clin. Oncol.'}
/ Proc. Am. Soc. Clin. Oncol. / Phase I trial in advanced malignancies with liposome-encapsulated paclitaxel (LEP) Q 3 weeks by Bowden (2002){'key': '10.1016/j.jconrel.2004.06.018_bib5', 'first-page': '1038', 'article-title': 'Phase I and pharmacokinetic study of ABI-007, a cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel', 'volume': '8', 'author': 'Ibrahim', 'year': '2002', 'journal-title': 'Clin. Cancer Res.'}
/ Clin. Cancer Res. / Phase I and pharmacokinetic study of ABI-007, a cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel by Ibrahim (2002)10.1016/S0168-3659(01)00299-1
/ J. Control. Release / Structure and design of polymeric surfactant-based drug delivery systems by Torchilin (2001)10.1016/S0169-409X(00)00124-1
/ Adv. Drug Deliv. Rev. / Block copolymer micelles for drug delivery: design, characterization and biological significance by Kataoka (2001)10.1517/14712598.1.4.583
/ Expert Opin. Biol. Ther. / Block copolymeric biotransport carriers as versatile vehicles for drug delivery by Alakhov (2001)10.2165/00137696-200402010-00002
/ Am. J. Drug Deliv. / Micelles in anticancer drug delivery by Le Garrec (2004)10.1016/j.addr.2003.07.013
/ Adv. Drug Deliv. Rev. / Polymeric micelles to deliver photosensitizers for photodynamic therapy by Van Nostrum (2004)10.1007/s002800050630
/ Cancer Chemother. Pharmacol. / An investigation of the antitumour activity and biodistribution of polymeric micellar paclitaxel by Zhang (1997)10.1016/S0168-3659(01)00275-9
/ J. Control. Release / In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy by Kim (2001)10.1023/A:1022243709003
/ Pharm. Res. / Sterically stabilized phospholipid mixed micelles: in vitro evaluation as a novel carrier for water-insoluble drugs by Krishnadas (2003)10.1016/S0168-3659(03)00162-7
/ J. Control. Release / Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(ɛ-caprolactone) copolymer as a carrier for paclitaxel by Lee (2003)10.1023/A:1011901921995
/ Pharm. Res. / Development of novel chitosan derivatives as micellar carriers of taxol by Miwa (1998)10.1002/(SICI)1099-1581(199911)10:11<647::AID-PAT918>3.0.CO;2-Y
/ Polym. Adv. Technol. / Core-stabilized polymeric micelle as potential drug carrier: increased solubilization of taxol by Kim (1999)10.1016/j.addr.2003.12.004
/ Adv. Drug Deliv. Rev. / Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs by Lukyanov (2004)10.1016/j.jconrel.2004.03.009
/ J. Control. Release / Antitumor characteristics of methoxypolyethylene glycol-poly(dl-lactic acid) nanoparticles containing campthotecin by Miura (2004)10.1016/j.ijpharm.2003.12.012
/ Int. J. Pharm. / All-trans-retinoic acid release from core shell type nanoparticles of poly(ε-caprolactone)/poly (ethylene glycol) diblock copolymer by Jeong (2004)10.1016/0378-5173(95)04386-1
/ Int. J. Pharm. / Development of amphiphilic diblock copolymers as micellar carriers of taxol by Zhang (1996)10.1023/A:1011054930439
/ Pharm. Res. / Novel polymeric micelles based on the amphiphilic diblock copolymer poly(N-vinyl-2-pyrrolidone)-block-poly(d,l-lactide) by Benhamed (2001)10.1002/jbm.820090505
/ J. Biomed. Mater. Res. / Cell adhesion to polymeric materials: implications with respect to biocompatibility by Ratner (1975)10.1002/jbm.820260707
/ J. Biomed. Mater. Res. / Biocompatibility studies on plasma polymerized interface materials encompassing both hydrophobic and hydrophilic surfaces by Johnson (1992)10.1081/PDT-100100550
/ Pharm. Dev. Technol. / Formulation and evaluation of vinylpyrrolidone/vinylacetate copolymer microspheres with carbamazepine. by Moneghini (2000){'key': '10.1016/j.jconrel.2004.06.018_bib25', 'first-page': '281', 'article-title': 'Novel Taxol formulation: polyvinylpyrrolidone nanoparticle-encapsulated Taxol for drug delivery in cancer therapy', 'volume': '8', 'author': 'Sharma', 'year': '1996', 'journal-title': 'Oncol. Res.'}
/ Oncol. Res. / Novel Taxol formulation: polyvinylpyrrolidone nanoparticle-encapsulated Taxol for drug delivery in cancer therapy by Sharma (1996)10.1016/0005-2736(94)90025-6
/ Biochim. Biophys. Acta / Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo by Torchilin (1994){'key': '10.1016/j.jconrel.2004.06.018_bib27', 'first-page': '6416', 'article-title': 'Antitumor activity of tumor necrosis factor-α conjugated with polyvinylpyrrolidone on solid tumors in mice', 'volume': '60', 'author': 'Kamada', 'year': '2000', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Antitumor activity of tumor necrosis factor-α conjugated with polyvinylpyrrolidone on solid tumors in mice by Kamada (2000)10.1016/j.jconrel.2003.09.014
/ J. Control. Release / Polyvinylpyrrolidone-drug conjugate: synthesis and release mechanism by D'souza (2003){'key': '10.1016/j.jconrel.2004.06.018_bib29', 'first-page': '190', 'article-title': 'Use of lyoprotectants in the freeze-drying of a model protein, Ribonuclease A', 'volume': '37', 'author': 'Townsend', 'year': '1988', 'journal-title': 'J. Parenter. Sci. Technol.'}
/ J. Parenter. Sci. Technol. / Use of lyoprotectants in the freeze-drying of a model protein, Ribonuclease A by Townsend (1988)- D. Le Garrec, M. Kabbaj, J.C. Leroux, Preparation of nanodispersion for pharmaceutical applications, US Patent 10,101,572, 2002.
10.1016/0378-4347(94)00117-0
/ J. Chromatogr., B, Biomed. Appl. / Reversed-phase high-performance liquid chromatographic determination of taxol in mouse plasma by Sharma (1994)10.1097/00007691-199706000-00014
/ Ther. Drug Monit. / A simple and reliable reverse-phase high-performance liquid chromatographic procedure for determination of paclitaxel (taxol) in human serum by Andreeva (1997)10.1021/ma035910q
/ Macromolecules / Novel amphiphilic diblock copolymer of low molecular weight poly(N-vinylpyrrolidone)-block-(d,l-lactide): synthesis, characterization and micellization by Luo (2004)10.1021/ma971111u
/ Macromolecules / Synthesis and solution properties of fluorescently labeled amphiphilic (N-alkylacrylamide) oligomers by Yamazaki (1998)10.1023/B:PHAM.0000029284.40637.69
/ Pharm. Res. / A novel one-step drug loading procedure for water-soluble amphiphilic nanocarriers by Fournier (2004)10.1016/0022-1759(83)90303-4
/ J. Immunol. Methods / Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay by Mosmann (1983)10.1016/S0168-3659(99)00114-5
/ J. Control. Release / The design and synthesis of polymers for eukaryotic membrane disruption by Murthy (1999)10.1016/0378-4347(94)00456-F
/ J. Chromatogr., B / Isocratic high-performance liquid chromatographic assay of taxol in biological fluids and tissues using automated column switching by Song (1995)10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F
/ Stat. Med. / Bootstrap confidence intervals: when, which, what? A practical guide for medical statisticians by Carpenter (2000)10.1126/science.1078192
/ Science / Micellar nanocontainers distribute to defined cytoplasmic organelles by Savic (2003)10.1016/S0939-6411(02)00119-4
/ Eur. J. Pharm. Biopharm. / Enhanced cellular accumulation of P-glycoprotein substrate, rhodamine 123, by Caco-2 cells using low molecular weight methoxypolyethylene glycol-block-polycaprolactone diblock copolymers by Zastre (2002)10.1002/macp.1985.021860406
/ Makromol. Chem. / Micelle-forming block copolymers: pinocytosis by macrophages and interaction with model membranes by Pratten (1985)10.1097/00001813-199801000-00001
/ Anti-Cancer Drugs / Preclinical pharmacokinetics of paclitaxel and docetaxel by Sparreboom (1998){'key': '10.1016/j.jconrel.2004.06.018_bib44', 'series-title': 'Taxol: Science and Applications', 'first-page': '209', 'article-title': 'Preclinical antitumor activity of taxanes', 'volume': 'vol. 8', 'author': 'Rose', 'year': '1995'}
/ Taxol: Science and Applications / Preclinical antitumor activity of taxanes by Rose (1995)10.3109/02652049009021832
/ J. Microencapsul / In vitro and in vivo antitumoral activity of free, and encapsulated taxol by Bartoli (1990)10.1023/A:1025021603288
/ Pharm. Res. / A high-throughput combinatorial approach for the discovery of a Cremophor EL-free paclitaxel formulation by Chen (2003){'key': '10.1016/j.jconrel.2004.06.018_bib47', 'first-page': '31', 'article-title': 'A new parenteral vehicle for the administration of some poorly water soluble anti-cancer drugs', 'volume': '41', 'author': 'Tarr', 'year': '1987', 'journal-title': 'J. Parenter. Sci. Technol.'}
/ J. Parenter. Sci. Technol. / A new parenteral vehicle for the administration of some poorly water soluble anti-cancer drugs by Tarr (1987)10.1023/A:1018943021705
/ Pharm. Res. / A mixed micellar formulation suitable for the parenteral administration of taxol by Alkan-Onyuksel (1994)10.1016/S0169-409X(02)00015-7
/ Adv. Drug Deliv. Rev. / Poly(ethylene oxide)-block-poly(l-amino acid) micelles for drug delivery by Lavasanifar (2002)10.1016/S0169-409X(02)00016-9
/ Adv. Drug Deliv. Rev. / Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations by Liggins (2002)10.1016/S0927-7765(99)00058-2
/ Colloids Surf., B / Nano-engineering block copolymer aggregates for drug delivery by Allen (1999)10.1002/jps.10533
/ J. Pharm. Sci. / Polymer-drug compatibility: a guide to the development of delivery systems for the anticancer agent, ellipticine by Liu (2004){'key': '10.1016/j.jconrel.2004.06.018_bib53', 'series-title': 'International Conference on Harmonization; Guidance on Impurities: Residual Solvents', 'first-page': '67377', 'author': 'Hubbarb', 'year': '1997'}
/ International Conference on Harmonization; Guidance on Impurities: Residual Solvents by Hubbarb (1997)10.1002/1097-0045(20000701)44:2<156::AID-PROS8>3.0.CO;2-8
/ Prostate / Polymeric micellar paclitaxel phosphorylates Bcl-2 and induces apoptotic regression of androgen-independent LNCaP prostate tumors by Leung (2000)10.1097/00001813-199708000-00008
/ Anti-Cancer Drugs / Anti-tumor efficacy and biodistribution of intravenous polymeric micellar paclitaxel by Zhang (1997)10.2165/00003088-200342070-00005
/ Clin. Pharmacokinet. / Pharmacological effects of formulation vehicles. Implications for cancer chemotherapy by Ten Tije (2003)10.1093/jnci/90.4.300
/ J. Natl. Cancer Inst. / Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study by Szebeni (1998)10.1016/S0959-8049(01)00171-X
/ Eur. J. Cancer / Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation by Gelderblom (2001)10.1016/S0168-3659(01)00451-5
/ J. Control. Release / Long-circulating poly(ethylene glycol)-poly(d,l-lactide) block copolymer micelles with modulated surface charge by Yamamoto (2001){'key': '10.1016/j.jconrel.2004.06.018_bib60', 'first-page': 'W4202', 'article-title': 'Ionically fixed polymeric nanoparticles as a novel drug carrier', 'volume': '4', 'author': 'Lee', 'year': '2002', 'journal-title': 'AAPS PharmSci'}
/ AAPS PharmSci / Ionically fixed polymeric nanoparticles as a novel drug carrier by Lee (2002){'key': '10.1016/j.jconrel.2004.06.018_bib61', 'first-page': '5877', 'article-title': 'Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model', 'volume': '53', 'author': 'Sharma', 'year': '1993', 'journal-title': 'Cancer Res.'}
/ Cancer Res. / Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model by Sharma (1993)10.1021/la035012n
/ Langmuir / Complex coacervation core micelles. Colloidal stability and aggregation mechanism by Van Der Burgh (2004)10.1021/bc034113u
/ Bioconjug. Chem. / Core-cross-linked polymeric micelles as paclitaxel carriers by Shuai (2004)10.1016/j.jconrel.2004.02.003
/ J. Control. Release / Folate receptor targeted biodegradable polymeric doxorubicin micelles by Yoo (2004)10.1073/pnas.0931428100
/ Proc. Natl. Acad. Sci. / Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs by Torchilin (2003)10.1080/1061186031000138623
/ J. Drug Target. / PEG-PE/phosphatidylcholine mixed immunomicelles specifically deliver encapsulated taxol to tumor cells of different origin and promote their efficient killing by Gao (2003)
@article{Le_Garrec_2004, title={Poly(N-vinylpyrrolidone)-block-poly(d,l-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluation}, volume={99}, ISSN={0168-3659}, url={http://dx.doi.org/10.1016/j.jconrel.2004.06.018}, DOI={10.1016/j.jconrel.2004.06.018}, number={1}, journal={Journal of Controlled Release}, publisher={Elsevier BV}, author={Le Garrec, D. and Gori, S. and Luo, L. and Lessard, D. and Smith, D.C. and Yessine, M.-A. and Ranger, M. and Leroux, J.-C.}, year={2004}, month=sep, pages={83–101} }